Results 201 to 210 of about 75,382 (270)

Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer. [PDF]

open access: yesGenes (Basel)
Rees A   +8 more
europepmc   +1 more source

The hypoxia adaptive response regulates metallothionein expression in intestinal epithelial cells [PDF]

open access: yes, 2011
De Vos, Martine   +4 more
core  

Home - About - Disclaimer - Privacy